vapc, an human endogenous inhibitor for hepatitis c virus (hcv) infection, is intrinsically unstructured but forms a “fuzzy complex” with hcv ns5bvapc,人类内源性抑制剂对丙型肝炎病毒(hcv)感染,本质上是结构化的但是形式与丙肝病毒ns5bu201c模糊复杂u201d.pdfVIP

下载本文档

3
0
约6.64万字
约 12页
2017-09-12 发布于上海
举报
版权申诉

vapc, an human endogenous inhibitor for hepatitis c virus (hcv) infection, is intrinsically unstructured but forms a “fuzzy complex” with hcv ns5bvapc,人类内源性抑制剂对丙型肝炎病毒(hcv)感染,本质上是结构化的但是形式与丙肝病毒ns5bu201c模糊复杂u201d.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

vapc, an human endogenous inhibitor for hepatitis c virus (hcv) infection, is intrinsically unstructured but forms a “fuzzy complex” with hcv ns5bvapc,人类内源性抑制剂对丙型肝炎病毒(hcv)感染,本质上是结构化的但是形式与丙肝病毒ns5bu201c模糊复杂u201d

VAPC, an Human Endogenous Inhibitor for Hepatitis C Virus (HCV) Infection, Is Intrinsically Unstructured but Forms a ‘‘Fuzzy Complex’’ with HCV NS5B 1 2 2 3 3 3 Shaveta Goyal , Garvita Gupta , Haina Qin , Megha Haridas Upadya , Yee Joo Tan , Vincent T. K. Chow , Jianxing Song1,2* 1 Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore, 2 Department of Biological Sciences, Faculty of Science, National University of Singapore, Singapore, Republic of Singapore, 3 Department of Microbiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore Abstract Nearly 200 million people are infected by hepatitis C virus (HCV) worldwide. For replicating the HCV genome, the membrane-associated machinery needs to be formed by both HCV non-structural proteins (including NS5B) and human host factors such as VAPB. Recently, the 99-residue VAPC, a splicing variant of VAPB, was demonstrated to inhibit HCV replication via binding to NS5B, thus acting as an endogenous inhibitor of HCV infection. So far, the structure of VAPC remains unknown, and its interaction with NS5B has not been biophysically characterized. In this study, we conducted extensive CD and NMR investigations on VAPC which led to several striking findings: 1) although the N-terminal 70 residues are identical in VAPC and VAPB, they constitute the characteristic b-barrel MSP fold in VAPB, while VAPC is entirely unstructured in solution, only with helical-like conformations weakly populated. 2) VAPC is indee